Clinical Trial Update: Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing a potassium-competitive acid blocker with a proton-pump inhibitor for gastroprotection in patients at high risk of GI bleeding …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Potassium-Competitive Acid Blocker (potassium-competitive acid blocker)
• Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Duk-Woo Park, MD | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Status: RECRUITING